Company Profile

BioGrowth Inc
Profile last edited on: 10/1/22      CAGE:       UEI:

Business Identifier: Naturally-occurring cell regulating proteins
Year Founded
1985
First Award
1986
Latest Award
1989
Program Status
Inactive
Popularity Index
Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.

Location Information

505 Ortega Street
San Francisco, CA 94122
   N/A
   N/A
   N/A
Location: Single
Congr. District: 12
County: San Francisco

Public Profile

In 1991 it was announced that San Jose based Celtrix Pharmaceuticals had merged with privately held BioGrowth. Both companies were focused on developing novel therapeutic products based on naturally-occurring cell regulating proteins. Later on - in May 2000, Celtrix Pharmaceuticals Inc. was acquired by Insmed Incorporated in a reverse merger transaction.

Extent of SBIR involvement

User Avatar

Synopsis: Awardee Business Condition

Employee Range
5-9
Revenue Range
.5M-1M
VC funded?
No
Public/Private
Privately Held
Stock Info
----
IP Holdings
N/A

Awards Distribution by Agency

Most Recent SBIR Projects

Year Phase Agency Total Amount
1989 1 NIH $50,000
Project Title: Identification of tissue specific IGF-CP variants
1988 1 NIH $50,000
Project Title: Monoclonal antibodies for a growth regulator
1987 2 NIH $550,000
Project Title: Regulation of biological growth

Key People / Management

  Christopher Arthur Maack

  Martin E Spencer

  Carol A Talkington Verser

Company News

There are no news available.